United Therapeutics UTHR
NASDAQ UTHR
$541.89 +60.42 (+12.55%)
At close: Sep 30, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Capital Leases (2009)

Updated

United Therapeutics (UTHR) reported Capital Leases of $30.33 million for Q4 2009.

Analysis

United Therapeutics (UTHR) Capital Leases (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 United Therapeutics 23.13 Bn 12.62 Bn 683.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 30.33 Mn
API Access

United Therapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=UTHR&period=max&api_key=YOUR_API_KEY